Ten researchers who have been supported by RPB will be co-principal investigators on five innovative projects just announced by the National Eye Institute (NEI) as part of its Audacious Goals Initiative (AGI) for Regenerative Medicine. In this latest AGI effort, the five multi-disciplinary teams will develop new disease models for a range of eye conditions. This AGI model-development effort seeks to catalyze new, regenerative treatments – such as cell- and gene-based therapies -- for such conditions as glaucoma, age-related macular degeneration and retinitis pigmentosa.
The two researchers comprising the Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research team both had RPB Career Development Awards (CDAs). The majority of team members on two other teams, Retinal Ganglion Cell Replacement in Optic Neuropathies and Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy, received earlier RPB funding. Many of these scientists were CDA recipients as well. The projects and RPB-associated team members include:
Project: Retinal Disease Models for Translational Photoreceptor Replacement (EY029890)
RPB-Supported Researcher:
Project: Retinal Ganglion Cell Replacement in Optic Neuropathies (EY029903)
RPB-Supported Researchers:
Project: Models of Cone Disorders and Other Heritable Retinal Diseases (EY029904)
RPB-Supported Researchers:
Project: Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research (EY029891)
RPB-Supported Researchers:
Project: Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy (EY029893)
RPB-Supported Researchers:
In announcing the projects, NEI Director Paul A. Sieving, MD, PhD stated: “Models that recapitulate human disease are essential to predicting the success of new therapies in humans. These audacious projects will be pivotal in our efforts to translate the latest science advances into new treatments for vision loss and blindness.”
October 23, 2018
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
The ARPA-H THEA project takes on an exciting challenge.
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |